Search

Displaying results 5361 - 5370 of 7687 in total
  1. Drug

    Ulotaront

    go.drugbank.com/drugs/DB15665
    Investigational

    [L12891] An initial clinical study has shown this drug may be effective against both positive and negative symptoms of schizophrenia. … Unlike other drugs used for this condition, SEP-363856 does not bind to the dopamine D2 receptors, but exerts actions on the trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5

  2. Drug

    Clometherone

    go.drugbank.com/drugs/DB19465
    Experimental

    Clometherone has a monoisotopic molecular weight of 362.2 Da.

  3. Drug

    Derquantel

    go.drugbank.com/drugs/DB19531
    Experimental

    Derquantel has a monoisotopic molecular weight of 479.28 Da.

  4. Drug

    Lasinavir

    go.drugbank.com/drugs/DB19546
    Experimental

    Lasinavir has a monoisotopic molecular weight of 659.38 Da.

  5. Drug

    Tomeglovir

    go.drugbank.com/drugs/DB19558
    Experimental

    Tomeglovir has a monoisotopic molecular weight of 441.17 Da.

  6. Drug

    Bepiastine

    go.drugbank.com/drugs/DB19791
    Experimental

    Bepiastine has a monoisotopic molecular weight of 299.11 Da.

  7. Drug

    Bleselumab

    go.drugbank.com/drugs/DB15253
    Investigational

    Bleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney

  8. Drug

    Haloprogesterone

    go.drugbank.com/drugs/DB20259
    Experimental

    Haloprogesterone has a monoisotopic molecular weight of 410.13 Da.

  9. Drug

    Noberastine

    go.drugbank.com/drugs/DB20429
    Experimental

    Noberastine has a monoisotopic molecular weight of 311.17 Da.

  10. Drug

    Levosemotiadil

    go.drugbank.com/drugs/DB20446
    Experimental

    Levosemotiadil has a monoisotopic molecular weight of 536.2 Da.